Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Latest filing published 24 Sept 2026 for Theravance Biopharma, Inc.. Read the official filing
Filing timeline
BuySaleRhonda Farnum
Insider track record
Disclosed buys
0
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Rhonda Farnum: trading record in brief
This profile gathers the share dealings of Rhonda Farnum in Theravance Biopharma, Inc., where the filings describe the role as senior executive. In total, 40 filings cover trades dated from 14 December 2021 to 23 September 2026.
Every open-market trade on record is a sale: 15 sales worth €880k. Other entries cover 23 share grants. In 2026 alone, the filings show no purchases and 4 sales.
Most recently, on 24 September 2026, the filings show a transaction in Theravance Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Rhonda Farnum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
124,414 sharesOrdinary SharesSEC:0001898490-26-000017:0
89,062 sharesOrdinary SharesSEC:0001898490-26-000017:1
3,328 shares@ US$17.03430.0064% mcap1.9% of flowOrdinary SharesSEC:0001898490-26-000014:1
3,329 shares@ US$17.03410.0064% mcap1.9% of flowOrdinary SharesSEC:0001898490-26-000014:0
6,657 shares@ US$17.03420.013% mcap3.7% of flowOrdinary SharesSEC:0001898490-26-000014:2
5,667 shares@ US$16.950.011% mcap3.3% of flowOrdinary SharesSEC:0001898490-26-000012:0
18,750 shares0Ordinary SharesSEC:0001898490-26-000006:0
7,767 shares@ US$13.91635.3% of flowOrdinary SharesSEC:0001898490-26-000004:0
13,929 shares@ US$19.669.8% of flowOrdinary SharesSEC:0001898490-26-000002:0
7,767 shares@ US$18.74995.8% of flowOrdinary SharesSEC:0001898490-25-000008:0
9,060 shares@ US$17.907.0% of flowOrdinary SharesSEC:0001898490-25-000006:0
9,096 shares@ US$13.395.6% of flowOrdinary SharesSEC:0001415889-25-022794:0
682 shares@ US$11.39270.4% of flowOrdinary SharesSEC:0001415889-25-019869:0
24,000 shares@ US$11.0013.8% of flowOrdinary SharesSEC:0001415889-25-015642:0
9,120 shares@ US$9.455.3% of flowOrdinary SharesSEC:0001415889-25-014257:0
4,000 shares@ US$9.002.2% of flowOrdinary SharesSEC:0001415889-25-011227:0
75,000 shares0Ordinary SharesSEC:0001415889-25-006668:0
5,283 shares0Ordinary SharesSEC:0001415889-25-005347:0
4,000 shares@ US$9.002.4% of flowOrdinary SharesSEC:0001415889-25-001957:0
9,178 shares@ US$9.976.0% of flowOrdinary SharesSEC:0001415889-24-027564:0
4,000 shares@ US$9.002.3% of flowOrdinary SharesSEC:0001415889-24-026766:0
9,222 shares@ US$8.224.7% of flowOrdinary SharesSEC:0001415889-24-022084:0
4,000 shares@ US$9.002.3% of flowOrdinary SharesSEC:0001415889-24-019534:0
9,268 shares@ US$9.105.4% of flowOrdinary SharesSEC:0001415889-24-014133:0
37,500 shares0Ordinary SharesSEC:0001415889-24-010320:0
25 of 40 declarations
